Tumor regression following the administration of 10 mg/kg GITRL-FP as a monotherapy was observed only in those CEA.Tg mice with low tumor volume on day 7 post-tumor inoculation (see Figure 1, Schedule A vs. B). Here, CEACAM5 is linked to neoplasm.